ITMCTR2000003349
Recruiting
Phase 1
Clinical study on the prevention of postoperative recurrence and metastasis of colorectal cancer by Zuojin pill combined with adjuvant chemotherapy
Shuguang Hospital affillated with Shanghai University of TCM0 sitesTBD
Conditionscolorectal cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- colorectal cancer
- Sponsor
- Shuguang Hospital affillated with Shanghai University of TCM
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Clear cytology and pathology diagnosis of colorectal cancer (TMN stage for III);
- •2\. The TCM syndrome type was consistent with the syndrome of irascibility in stomach and gastrointestinal dampness and heat.
- •3\. Chemotherapy was planned, and there were no other treatment plans such as radiotherapy, interventional therapy, targeting and immunization during the study period.
- •4\. 1 month before the test, no traditional Chinese medicine, proprietary Chinese medicine or traditional Chinese medicine injection was used for the treatment.
- •5\. Urine HCG test is available for both men and women, aged 18\-80 years and of childbearing age.
- •6\. Physical condition score: KPS score: 70 or above;
- •7\. The estimated survival time is 6 months or more;
- •8\. The peripheral blood image was normal, and there were no obvious abnormalities in the cardiac, hepatic, renal and electrocardiogram.
- •9\. No cognitive impairment, willing to participate in this study, able to receive relevant treatment and physical and chemical examinations and sign an informed consent.
Exclusion Criteria
- •1\. Patients with serious diseases such as cardiovascular system, respiratory system, digestive system, urogenital system, blood system and rheumatic immune system, who cannot tolerate treatment;
- •2\. People with mania, depression, anxiety, schizophrenia, active tuberculosis and other serious infectious diseases;
- •3\. Cancer pain, intestinal obstruction, ascites and other serious tumor complications;
- •4\. Patients who had received radiotherapy, interventional therapy, targeted therapy, immunization and other treatments in the past 2 months;
- •5\. Those who had been enrolled in other experimental drugs in the past 2 months;
- •6\. Those who cannot be treated by TCM compound due to allergy or other reasons;
- •7\. The researcher considers it inappropriate to participate in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Early Phase 1
Clinical study on prevention of perioperative neurocognitive impairment by Baihui and Shenting electroacupunctureperioperative neurocognitive impairmentITMCTR2024000150People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Active, not recruiting
Not Applicable
Klinische Studie zum Einfluss einer postoperativen Verabreichung von (S)-(+)-Ketamin auf das Schmerzempfinden nach großen chirurgischen Eingriffen - Ketanest®S-Schmerz-StudiePostoperatives Schmerzempfinden bei elektiven großen bauchchirurgischen Eingriffen, transabdominellen urologischen Eingriffe oder transabdominellen gynäkologischen EingriffenEUCTR2006-000714-20-ATDr. Wolfgang Jaksch150
Not yet recruiting
Phase 1
Evidence based medicine study on prevention of postoperative recurrence and metastasis of non-small cell lung cancer with traditional Chinese Medicineon small cell lung cancerITMCTR2022000017Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Not yet recruiting
Not Applicable
Clinical studies for the prevention of postoperative delirium in oral cancerOral cancer,DeliriumJPRN-UMIN000042066Tokyo Medical and Dental University1,600
Active, not recruiting
Phase 1
Prevention of heart and lung complications by using simvastatin in patients undergoing surgery for removal of food pipeEUCTR2015-004424-65-GBBelfast Health and Social Care Trust452